| INTRODUC TI ON
The rapid expansion of medical literature in recent decades has provided increased access to evidence that can improve healthcare delivery, yet much of this information has been published without curation, thereby limiting translation into practice. [1] [2] [3] [4] To address this, clinical practice guidelines (CPGs) were developed to provide synthesised and critically appraised scientific evidence to enhance medical decision-making. CPGs aim to advance the quality of healthcare delivery through acceleration of knowledge translation, promotion of cost-effective practices and reduction of practice variation. 5 There has been a notable increase in the publication and use of CPGs among various medical specialty societies, healthcare institutions and governmental bodies. [5] [6] [7] [8] This increase, however, has raised concern about the lack of standardisation in the CPG development process and information presentation, 3, [9] [10] [11] and this has motivated initiatives to formalise methods for guideline appraisal. One of the many medical specialties promulgating CPGs is emergency medicine.
Guidelines specifically for emergency care were first published by the was removed from the website's "current" list but remained in this study, as it was current at the time of initial guideline selection. 
| Data abstraction
The data were abstracted using the electronic web tool created by the AGREE II developers, available at http://www.agreetrust.org/.
This instrument consists of 23 key items organised within six quality domains and two additional global assessments. Each item is rated on a Likert scale between one (strongly disagree) and seven (strongly agree). Each domain captures a unique dimension of guideline quality, specifically "Scope and Purpose," "Stakeholder Involvement," "Rigor of Development," "Clarity of Presentation,"
"Applicability" and "Editorial Independence" (Appendix S1).
"Scope and Purpose" addresses the overall aim of the guideline, the specific health questions and the target population (patients, the public, etc.). "Stakeholder Involvement" focuses on the extent to which the guideline development group includes individuals from all relevant professional groups, represents the views of its intended users and clearly defines its target population. "Rigor of Development" relates to the process utilised to gather and synthesise the evidence, the methods utilised to formulate the recommendations, and the criteria used to update them. "Clarity of Presentation" addresses the language, structure and format of the guideline.
"Applicability" pertains to factors affecting guideline implementation, strategies to improve uptake and resource implications of applying the recommendations in practice. "Editorial Independence"
assesses whether the views of the funding body have influenced the content of the guideline and whether competing interests of guideline group members have been recorded and addressed.
After completing assessments for each of the six domains, the instrument prompts the reviewer for an "Overall Assessment" of the guideline (using the same 1-7 Likert scale) and a categorical recommendation for use in clinical practice ("yes," "yes with modification" or "no"). These two global assessments are based on the reviewer's overall impression of the guideline and are not calculated from item or domain ratings.
| Group appraisal process
The appraisal process was performed to exceed recommendations of the AGREE II instrument developers. The AGREE II developers recommend a minimum of two appraisers and optimally four appraisers for stable estimates of CPG quality. In our study, all twenty ACEP clinical policies were reviewed by five appraisers (AZ, TT, GS, KC and MJ). Prior to data abstraction, each appraiser completed a standardised online training module specifically for use of AGREE II, [18] [19] [20] [21] [22] and a group session was conducted after reviewing the first three guidelines to ensure consistent use of definitions and to optimise inter-rater reliability. All appraisals were performed independently between May 2017 and September 2017. Each appraiser was assigned a unique and random order to perform the data abstraction to minimise bias as a result of increased familiarity with the instrument over time.
| Data abstraction for underlying evidence and recommendations
Each clinical policy contains clinical recommendations based on medical literature to address critical questions faced by emergency physicians. For each recommendation found in a clinical policy, we recorded the proportion of recommendations that were Level C (the weakest level of recommendation) (Table S1 ). Level C recommendations are based on evidence from Design Class III studies or expert consensus. We also recorded the proportion of references within each clinical policy that were graded as Design Class III evidence.
Studies considered as Class III evidence are case series, case reports, consensus or review papers, and studies with a higher level of design were downgraded by the Committee based on issues with study quality.
| Outcomes
The primary outcomes were AGREE II ratings for each item, domain, "Overall Assessment" and recommendation for use in clinical practice.
| Analysis
For the primary descriptive analysis, domain and "Overall Assessment" ratings were standardised as a percentage according to the following formula recommended by AGREE II developers 18 :
The standardised score using this formula was determined for In addition to utilising multiple appraisers, we also assessed agreement across the five appraisers. We first considered calculation of the intra-class coefficients (ICC) to measure inter-rater reliability but found ICC values unrepresentative of raw agreement given the narrow distribution of ratings and therefore used an alternative method to assess inter-rater agreement. We classified each appraiser's domain rating into three categories based on sentiment (1-3, "disagree"; 4, "neutral"; 5-7 "agree"). As a strict assessment of agreement, we calculated the percentage of appraisals for each item for which all appraisers reported the same sentiment category rating. This provides an easily interpretable measure of agreement between appraisers. We observed varying degrees of agreement in sentiment categories by domain: "Scope and Purpose" 97%, "Stakeholder Involvement" 62%, "Rigor of Development" 44%, "Editorial Independence" 28% and "Applicability" 1%. The chi-squared statistic was statistically significant at P < 0.0001 for each domain, indicating that the rate at which all raters agreed was significantly greater than would be expected if ratings were random.
For all analysis, we considered alpha equal to or less than 0.05 to be statistically significant, and we accounted for multiple comparisons using a Bonferroni correction where appropriate. 23 Data analysis was performed using R statistical software (version 3.4.2). This was not considered human subjects research.
| RE SULTS
This study included twenty current clinical policies published by (Table S2) .
Of the six AGREE II domains, "Scope and Purpose" had the highest mean rating and the lowest variability (mean 90%, coefficient of variation [CV] 0.03) ( Table 1 ). "Applicability" had the lowest mean rating and highest variability (mean 35%, CV 0.16). The four remaining domains, from highest to lowest rating, were "Rigor of Development," "Clarity of Presentation," "Editorial Independence"
and "Stakeholder Involvement." The mean results from the standardised scores of all five reviewers are provided in Table S3 .
For the "Overall Assessment," the mean rating for all twenty clinical policies from the five appraisers was 69% with CV of 0.13
( Table 1 ). The categorical assessment of recommendation for clinical use was evaluated by practicing emergency physicians, and the recorded responses were considered to be summary recommendations based on the overall impression of the policy. The vast majority of responses were "yes" or "yes with modifications" (64% and 30%, respectively). There were, however, "no" responses for clinical policies on asymptomatic elevated blood pressure, prescribing opioids for adult patients, suspected appendicitis and acute carbon monoxide poisoning. These four clinical policies also had the four lowest mean "Overall Assessment" ratings of all clinical policies in this study (50%, 53%, 50% and 63%, respectively).
There was no significant relationship between "Overall Assessment" rating and date of policy publication ( Figure S1 ). Further, there was no significant improvement in the "Overall Assessment" ratings or in any of the six domains after updates to ACEP clinical policy development process in September 2015 (Table 2) .
Two domains were statistically associated with the "Overall Assessment" rating: "Rigor of Development" (correlation [r] = 0.70, P < 0.001) and "Clarity of Presentation" (r = 0.77, P < 0.0001) ( Table 3 ). The other four domains' ratings were not strongly associated with "Overall Assessment" rating (r = 0.01-0.51).
There was no significant association between "Overall Assessment" and either the proportion of Level C recommendations 
| D ISCUSS I ON
Overall, ACEP clinical policies rated highly based on the validated AGREE II instrument for guideline quality. There was, however,
TA B L E 1 AGREE II ratings for each domain and overall assessment

Scope and purpose
Stakeholder involvement
Rigor of development
Clarity of presentation Applicability Editorial independence
Overall assessment Further, explanation should be provided about how these conflict of interests are managed and accounted for (ie, whether certain competing interests excluded members from specific aspects of guideline development). While our results did not demonstrate improvement in AGREE II ratings over time, this should not be interpreted as a barrier to developing more effective guidelines. ACEP could consider these targeted improvements in the development process to improve the quality of its clinical policies.
In addition to domain ratings, the mean "Overall Assessment"
rating for all 20 clinical policies was quite high, indicating the global strength of the ACEP clinical policy development methodology. In contrast to the domain ratings, however, the "Overall Assessment"
does not include detailed criteria and is based on the appraiser's general impression of the policy. Given the inclusion of both formulaic and subjective elements in this instrument, it should be noted to those interpreting AGREE II ratings that "Overall Assessment" scores are distinct from the item-defined domain ratings. The association we found between "Overall Assessment" ratings and both "Rigor of Development" and "Clarity of Presentation" suggest that strong performance on these two domains may be influential on the appraiser's overall impression of the policy's quality. This extends the findings of Hoffmann-Esser et al, 37 which examined AGREE II ratings for 1453 guidelines and found that "Rigor of Development" had the strongest correlation with the "Overall Assessment" rating. Guideline developers can use this information for targeted improvements in these two domains to best meet the needs of those utilising their guidelines.
Our finding that AGREE II ratings were not sensitive to the pol- 
| S TRENG TH S AND LIMITATI ON S
The findings of this work should be interpreted within the confines of the strengths and weaknesses of its design. This study exceeded the Finally, our analysis was limited to guidelines developed by ACEP and did not include any guidelines published by other specialty societies, in other countries or in other languages; therefore, many guidelines that are pertinent to emergency care but developed by other specialties or organisations are absent from this work.
| CON CLUS IONS
ACEP clinical policies rated highly and had notable strengths and weaknesses based on validated criteria provided by the AGREE II instrument. Guideline quality did not improve over time or after ACEP methodological updates in 2015 and is not related to the quality of underlying evidence. ACEP clinical policies can be improved by including patient representation in the guideline development process, enhancing editorial independence and transparency and addressing factors that influence the application of these policies in clinical practice. 
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